ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Project Statistician at Eli Lilly and Company - ApplyBlast

Project Statistician

Eli Lilly and Company

1 month ago

4.0 on Glassdoor

Remote

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Project Statistician at the Director level provides statistical leadership in clinical plans, innovative study designs, and data analysis to support drug development. This role involves shaping internal and external environments to improve the effectiveness of drug development while championing breakthrough statistical methodologies. The position requires influencing team decisions, managing critical risks, and integrating information to make data-driven choices for life-changing medicines.

Responsibilities

Lead development of clinical plans and innovative study designs
Select statistical methods and author statistical analysis plans
Communicate study results via regulatory submissions and presentations

Skills

Qualifications

Ph.D. in StatisticsPh.D. in Biostatistics

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.